Company intelligence / Profile preview

Sapphire Research

San Diego, California, United Statesle.ac.uk ↗
Ownership
Private
Development stage
Preclinical
01

Overview

Sapphire Biotech developed small molecule inhibitors targeting QSOX1 for potential use in cancer diagnosis and therapy. Their lead compound(s) were at pre-clinical stage prior to acquisition. They received a $395,880 SBIR Phase I grant from the National Cancer Institute to support this work.

Therapeutic areas
Oncology
Modalities
Small molecules (notably QSOX1 inhibitors such as SBI-183 and SPX-1009)
Industry
Biotech
02

Drug pipeline

1 asset

SBI-183

Pre-clinical
Indications
breast cancer, kidney cancer, pancreatic cancer
03

Partnerships

Skysong Innovations LLC (Arizona State University’s IP management arm—technology licensing partner)Mayo Clinic Arizona & Dr. Doug Lake’s laboratory at Arizona State University—academic research collaboration partners evaluating analog inhibitors for tumor biology studies

Beyond the preview

Go deeper on Sapphire Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sapphire Research.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call